New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...

Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera ...

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% ...

These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Gaps are information. They are the place on the chart where you can see buyers and sellers jumping ahead to a fast repricing, ...

In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now. Following a turbulent year for the markets in general and biotech in particular, the industry made a notable ...

Biotech, especially small-cap names, is experiencing renewed optimism as macro and policy headwinds subside. Read more on ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.

Chief Market Strategist at SlateStone Wealth, Llc Kenny Polcari joins Stuart Varney to discuss Bitcoin’s rally, Moderna’s ...

Edesa Biotech, Inc. EDSA shares fell nearly 13% in Thursday premarket trading after the company priced a $25 million public ...